AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8415401 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered solution of didanosine in humans
Number of subjects: 0
Study 3317334 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 16
Study 3317334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30170424 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injections, 0.9% sodium chloride injections as control, administered once per week for 3 weeks
Number of subjects: 27
Study 30170424 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride injections (control)
Number of subjects: 27
Study 30170424 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injections
Number of subjects: 27
Study 28850535 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) in TKA
Number of subjects: 55
Study 28850535 — intervention group
Group type: COMPARATOR
Intervention: Femoral block
Number of subjects: 55
Study 28850535 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) in THA
Number of subjects: 55
Study 28850535 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with 30mg ketorolac
Number of subjects: 55
Study 28850535 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with ketorolac
Number of subjects: 55
Study 23738786 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention (LEAP Beep) for 12 weeks
Number of subjects: 34
Study 23738786 — intervention group
Group type: COMPARATOR
Intervention: Control group (weight checks only)
Number of subjects: 34
Study 22457293 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7 (7-valent pneumococcal conjugate vaccine)
Number of subjects: 0
Study 22457293 — intervention group
Group type: COMPARATOR
Intervention: 23vP (23-valent unconjugated pneumococcal polysaccharide vaccine)
Number of subjects: 0
Study 22457293 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7 after 23vP
Number of subjects: 0
Study 22457293 — intervention group
Group type: COMPARATOR
Intervention: 23vP
Number of subjects: 0
Study 20370483 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 840
Study 20370483 — intervention group
Group type: COMPARATOR
Intervention: Delayed circumcision (control)
Number of subjects: 840
Study 19815630 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS 10 min 1.5 mA
Number of subjects: 17
Study 19815630 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS 20 min 1 mA
Number of subjects: 17
Study 19815630 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS 10 min 1.5 mA
Number of subjects: 17
Study 19815630 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 17
Study 15694942 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg
Number of subjects: 338
Study 12853045 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical heart valve prosthesis
Number of subjects: 556
Study 10505725 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-mm Microvasive balloon dilator inflated for 15 sec
Number of subjects: 24
Study 10505725 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-mm Microvasive balloon dilator inflated for 60 sec
Number of subjects: 24
Study 10505725 — intervention group
Group type: EXPERIMENTAL
Intervention: 35-mm Microvasive balloon dilator inflated for 15 sec
Number of subjects: 24
Study 10505725 — intervention group
Group type: EXPERIMENTAL
Intervention: 35-mm Microvasive balloon dilator inflated for 60 sec
Number of subjects: 24
Study 10505725 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 24
Study 8984862 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh blade
Number of subjects: 40
Study 8984862 — intervention group
Group type: COMPARATOR
Intervention: McCoy blade
Number of subjects: 40
Study 2015484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia at 28 degrees C
Number of subjects: 16
Study 2015484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia at 20 degrees C
Number of subjects: 16
Study 6756273 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (M)
Number of subjects: 7
Study 6756273 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (P)
Number of subjects: 7
Study 6756273 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (M) and Propranolol (P)
Number of subjects: 7
Study 6756273 — intervention group
Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 7
Study 31901782 — intervention group
Group type: EXPERIMENTAL
Intervention: Pythagorean Self-Awareness Intervention (PSAI)
Number of subjects: 45
Study 31901782 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 30094387 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralized arm via telemedicine center (virtual study conduct)
Number of subjects: 23
Study 30094387 — intervention group
Group type: COMPARATOR
Intervention: Conventional arm via health clinic (onsite study conduct)
Number of subjects: 23
Study 30094387 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralized arm
Number of subjects: 23
Study 30094387 — intervention group
Group type: COMPARATOR
Intervention: Conventional arm
Number of subjects: 23
Study 27048949 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen exposure under normal nasal breathing
Number of subjects: 25
Study 27048949 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen exposure with nasal blockage
Number of subjects: 25
Study 27048949 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure with nasal blockage
Number of subjects: 25
Study 25024314 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-288 1 mg
Number of subjects: 242
Study 25024314 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-288 3 mg
Number of subjects: 242
Study 25024314 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg
Number of subjects: 242
Study 25024314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 21895392 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous presentation
Number of subjects: 144
Study 21895392 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced presentation
Number of subjects: 144
Study 21895392 — intervention group
Group type: COMPARATOR
Intervention: Massed presentation
Number of subjects: 144
Study 20140523 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy with recombinant human arylsulfatase B (rhASB) at 1 mg/kg weekly for up to 240 weeks
Number of subjects: 56
Study 18762755 — intervention group
Group type: EXPERIMENTAL
Intervention: Context-sensitive analgesia
Number of subjects: 0
Study 18762755 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroprotective agents
Number of subjects: 0
Study 15877184 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX) - Group I (167 U)
Number of subjects: 45
Study 15877184 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX) - Group II (322 U)
Number of subjects: 45
Study 15877184 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX) - Group III (540 U)
Number of subjects: 45
Study 12600722 — intervention group
Group type: EXPERIMENTAL
Intervention: AAMI patients
Number of subjects: 43
Study 12600722 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects
Number of subjects: 43
Study 12600722 — intervention group
Group type: COMPARATOR
Intervention: Normal aging
Number of subjects: 43
Study 10625872 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 5 cmH2O
Number of subjects: 10
Study 10625872 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 10 cmH2O
Number of subjects: 10
Study 10625872 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 15 cmH2O
Number of subjects: 10
Study 10625872 — intervention group
Group type: COMPARATOR
Intervention: ZEEP (Control)
Number of subjects: 10
Study 8858268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 0.5 mg daily
Number of subjects: 135
Study 8858268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 1.0 mg daily
Number of subjects: 135
Study 8858268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg daily
Number of subjects: 135
Study 8858268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 1298871 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (OH-TRY) 500 mg
Number of subjects: 17
Study 1298871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 6370283 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (single dose)
Number of subjects: 0
Study 6370283 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (single dose)
Number of subjects: 0
Study 6370283 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (chronic treatment)
Number of subjects: 0
Study 6370283 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (chronic treatment)
Number of subjects: 0
Study 6370283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30477333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun Safe Workplaces (SSW) intervention promoting occupational sun safety policy and education
Number of subjects: 1784
Study 28322759 — intervention group
Group type: EXPERIMENTAL
Intervention: Steep ramp test (SRT) for predicting Vo2peak
Number of subjects: 283
Study 28322759 — intervention group
Group type: EXPERIMENTAL
Intervention: Steep ramp test (SRT) for predicting Wpeak
Number of subjects: 283
Study 28322759 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction model for Vo2peak
Number of subjects: 283
Study 28322759 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction model for Wpeak
Number of subjects: 283
Study 28322759 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction model for endurance exercise prescription
Number of subjects: 283
Study 27058799 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH + rosuvastatin
Number of subjects: 234
Study 27058799 — intervention group
Group type: COMPARATOR
Intervention: LMWH
Number of subjects: 234
Study 25139469 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean-variance regression calibration approach
Number of subjects: 0
Study 25139469 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up time regression calibration approach
Number of subjects: 0
Study 25139469 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction methods applied to Women's Health Initiative hormone therapy trials
Number of subjects: 0
Study 21728788 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted balloon catheter with 1000 mL fluid bag
Number of subjects: 60
Study 21728788 — intervention group
Group type: COMPARATOR
Intervention: Unweighted balloon catheter taped to the thigh
Number of subjects: 60
Study 21728788 — intervention group
Group type: COMPARATOR
Intervention: Unweighted balloon catheter
Number of subjects: 60
Study 21728788 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted balloon catheter
Number of subjects: 60
Study 19097106 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg contrast agent
Number of subjects: 24
Study 19097106 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mmol/kg contrast agent
Number of subjects: 24
Study 17959539 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil combined with sufentanyl
Number of subjects: 80
Study 17959539 — intervention group
Group type: COMPARATOR
Intervention: Sufentanyl alone
Number of subjects: 80
Study 15871189 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril for 8 weeks
Number of subjects: 42
Study 15871189 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan for 8 weeks
Number of subjects: 42
Study 15871189 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 42
Study 10720857 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily
Number of subjects: 447
Study 10720857 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 2.5 mg thrice daily
Number of subjects: 447
Study 10720857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study 9368810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle education (Group 1)
Number of subjects: 61
Study 9368810 — intervention group
Group type: COMPARATOR
Intervention: Standard education programme (Group 2)
Number of subjects: 61
Study 1392679 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine spray with frigen, two applications (20 mg lidocaine)
Number of subjects: 130
Study 1392679 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylestesin spray with frigen, two applications (14 mg lidocaine)
Number of subjects: 130
Study 1392679 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylestesin spray with frigen, three applications (21 mg lidocaine)
Number of subjects: 130
Study 1392679 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylestesin pump spray without frigen, two applications (14 mg lidocaine)
Number of subjects: 130
Study 1392679 — intervention group
Group type: COMPARATOR
Intervention: no topical anesthesia
Number of subjects: 130
Study 3926832 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine toothpaste (0.8% chlorhexidine, 0.1% amine fluoride)
Number of subjects: 9
Study 3926832 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-containing toothpaste (1.7 U/g glucose oxidase, 8.0 U/g amyloglucosidase, 0.1% amine fluoride)
Number of subjects: 9
Study 3926832 — intervention group
Group type: COMPARATOR
Intervention: Positive control (1% Hibitane dental gel)
Number of subjects: 9
Study 3926832 — intervention group
Group type: COMPARATOR
Intervention: Negative control (Vademecum MFP Fluor)
Number of subjects: 9
Study 30973547 — intervention group
Group type: EXPERIMENTAL
Intervention: +NENS (nutrition education and nutrition supplements)
Number of subjects: 600
Study 30973547 — intervention group
Group type: EXPERIMENTAL
Intervention: +NS (nutrition supplements)
Number of subjects: 600
Study 30973547 — intervention group
Group type: EXPERIMENTAL
Intervention: +NS (nutrition supplements) and +NENS (nutrition education and nutrition supplements)
Number of subjects: 600
Study 30973547 — intervention group
Group type: COMPARATOR
Intervention: +SE (standard education alone)
Number of subjects: 600
Study 29334582 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse (8% maltodextrin)
Number of subjects: 13
Study 29334582 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse (PLA)
Number of subjects: 13
Study 26687921 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual fear-related information (I)
Number of subjects: 48
Study 26687921 — intervention group
Group type: COMPARATOR
Intervention: Perceptual cues (C)
Number of subjects: 48
Study 26687921 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both (CI)
Number of subjects: 48
Study 26687921 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological parameters
Number of subjects: 48
Study 23135690 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 mL/kg‐1 at a rate of 10 breaths/minute (Group 10)
Number of subjects: 100
Study 23135690 — intervention group
Group type: COMPARATOR
Intervention: Tidal volume of 5 mL/kg‐1 with 5 cmH2O PEEP at a rate of 20 breaths/minute (Group 5)
Number of subjects: 100
Study 20616415 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE)
Number of subjects: 30
Study 20616415 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 30
Study 18484415 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g vitamin C
Number of subjects: 26
Study 18484415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 16368837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position during initiation of small-dose combined spinal-epidural anesthesia (CSE)
Number of subjects: 60
Study 16368837 — intervention group
Group type: COMPARATOR
Intervention: Lateral position during initiation of small-dose combined spinal-epidural anesthesia (CSE)
Number of subjects: 60
Study 14576510 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg once daily (increased to 300 mg if necessary)
Number of subjects: 60
Study 14576510 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg once daily (increased to 10 mg if necessary)
Number of subjects: 60
Study 11004326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent ceftazidime infusion
Number of subjects: 31
Study 11004326 — intervention group
Group type: COMPARATOR
Intervention: Continuous ceftazidime infusion
Number of subjects: 31
Study 8817536 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind subjects (early blind)
Number of subjects: 10
Study 8817536 — intervention group
Group type: COMPARATOR
Intervention: Blindfolded sighted subjects
Number of subjects: 10
Study 1451928 — intervention group
Group type: EXPERIMENTAL
Intervention: Original product (Duocid)
Number of subjects: 20
Study 1451928 — intervention group
Group type: COMPARATOR
Intervention: Generic formulation
Number of subjects: 20
Study 3711028 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (1, 2, and 5 mg/day for 2 weeks)
Number of subjects: 16
Study 3711028 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine (25, 50, and 75 mg/day for 2 weeks)
Number of subjects: 16
Study 3711028 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 16
Study 3711028 — intervention group
Group type: COMPARATOR
Intervention: Thioridazine
Number of subjects: 16
Study 29763659 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 160/14.4/10 μg
Number of subjects: 20
Study 29763659 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/14.4/10 μg
Number of subjects: 20
Study 29763659 — intervention group
Group type: COMPARATOR
Intervention: BGF MDI 160/14.4/10 μg and BGF MDI 320/14.4/10 μg
Number of subjects: 20
Study 27605034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) - strategy-based and drill-and-practice
Number of subjects: 75
Study 27605034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR)
Number of subjects: 75
Study 27605034 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 75
Study 25140909 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1265744 LA 800 mg IM
Number of subjects: 8
Study 25140909 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1265744 LA
Number of subjects: 8
Study 22334087 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-ED blog
Number of subjects: 421
Study 22334087 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help blog
Number of subjects: 421
Study 22334087 — intervention group
Group type: COMPARATOR
Intervention: Neutral control blog
Number of subjects: 421
Study 19671948 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urinary iodine
Number of subjects: 997
Study 19671948 — intervention group
Group type: EXPERIMENTAL
Intervention: Goiter presence
Number of subjects: 997
Study 19671948 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive anti-TPO antibodies
Number of subjects: 997
Study 19671948 — intervention group
Group type: EXPERIMENTAL
Intervention: Median urinary iodine
Number of subjects: 997
Study 17681307 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 77
Study 17681307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 microg)
Number of subjects: 77
Study 20057257 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based medication reconciliation (CMR) system, involving a clinical pharmacist visiting patients' homes within 72 hours of hospital discharge.
Number of subjects: 0
Study 20057257 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based medication reconciliation (CMR) system
Number of subjects: 0
Study 15928790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation and work therapy
Number of subjects: 0
Study 11319626 — intervention group
Group type: EXPERIMENTAL
Intervention: SSM+ (semisolid meal with modified guar gum)
Number of subjects: 28
Study 11319626 — intervention group
Group type: EXPERIMENTAL
Intervention: SSM (semisolid meal without modified guar gum)
Number of subjects: 28
Study 11319626 — intervention group
Group type: EXPERIMENTAL
Intervention: SM (solid meal)
Number of subjects: 28
Study 9386662 — intervention group
Group type: EXPERIMENTAL
Intervention: PRISM III-APS score
Number of subjects: 11165
Study 9386662 — intervention group
Group type: COMPARATOR
Intervention: PRISM III
Number of subjects: 11165
Study 8427664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricuff (Pressure Group AB, Stockholm)
Number of subjects: 20
Study 8427664 — intervention group
Group type: COMPARATOR
Intervention: Large standard cuff (rubber bag 12 x 35 cm)
Number of subjects: 20
Study 3105986 — intervention group
Group type: EXPERIMENTAL
Intervention: Human Insulin (HI)
Number of subjects: 21
Study 3105986 — intervention group
Group type: COMPARATOR
Intervention: Porcine Insulin (PI)
Number of subjects: 21
Study 12095665 — intervention group
Group type: COMPARATOR
Intervention: 0 mg (placebo)
Number of subjects: 8
Study 12095665 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of oral cocaine HCl
Number of subjects: 8
Study 12095665 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of oral cocaine HCl
Number of subjects: 8
Study 12095665 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of oral cocaine HCl
Number of subjects: 8
Study 29901753 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 µg folic acid daily (as part of a multivitamin) throughout pregnancy and lactation until 8 weeks postpartum
Number of subjects: 117
Study 25744954 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) with personalized feedback
Number of subjects: 98
Study 25744954 — intervention group
Group type: COMPARATOR
Intervention: Interactive education
Number of subjects: 98
Study 24266524 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking position during suctioning
Number of subjects: 34
Study 24266524 — intervention group
Group type: COMPARATOR
Intervention: Suctioning without intervention
Number of subjects: 34
Study 22330010 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 50
Study 22330010 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesia (oral diclofenac and metamizol, local lidocaine)
Number of subjects: 50